| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pancreatic Neoplasms | 22 | 2025 | 341 | 4.760 |
Why?
|
| Carcinoma, Pancreatic Ductal | 16 | 2025 | 111 | 3.670 |
Why?
|
| Epithelial-Mesenchymal Transition | 8 | 2025 | 67 | 1.730 |
Why?
|
| Cell Plasticity | 7 | 2025 | 18 | 1.620 |
Why?
|
| Cell Lineage | 2 | 2025 | 270 | 1.010 |
Why?
|
| Neoplasms | 4 | 2024 | 1364 | 0.980 |
Why?
|
| Acinar Cells | 4 | 2024 | 8 | 0.960 |
Why?
|
| Tumor Escape | 1 | 2024 | 16 | 0.870 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2024 | 26 | 0.860 |
Why?
|
| Pancreatic Ducts | 4 | 2021 | 30 | 0.860 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2024 | 206 | 0.840 |
Why?
|
| Immune Evasion | 1 | 2024 | 68 | 0.830 |
Why?
|
| Pancreas, Exocrine | 1 | 2021 | 12 | 0.710 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2021 | 8 | 0.700 |
Why?
|
| Pluripotent Stem Cells | 1 | 2021 | 74 | 0.680 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 114 | 0.660 |
Why?
|
| Cell Line, Tumor | 16 | 2025 | 1471 | 0.650 |
Why?
|
| Mice | 25 | 2025 | 10846 | 0.650 |
Why?
|
| Animals | 29 | 2025 | 20666 | 0.580 |
Why?
|
| Gene Expression Regulation, Neoplastic | 8 | 2025 | 525 | 0.560 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2016 | 1 | 0.520 |
Why?
|
| Neoplasm Metastasis | 6 | 2025 | 200 | 0.510 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2016 | 62 | 0.500 |
Why?
|
| Carcinogenesis | 4 | 2024 | 130 | 0.500 |
Why?
|
| Stromal Cells | 1 | 2016 | 68 | 0.500 |
Why?
|
| Chemokines | 1 | 2016 | 93 | 0.490 |
Why?
|
| Metaplasia | 3 | 2024 | 18 | 0.480 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2024 | 56 | 0.380 |
Why?
|
| Tumor Microenvironment | 5 | 2025 | 158 | 0.360 |
Why?
|
| Disease Models, Animal | 8 | 2024 | 2187 | 0.350 |
Why?
|
| Mice, Knockout | 6 | 2024 | 2109 | 0.350 |
Why?
|
| Organoids | 2 | 2021 | 43 | 0.350 |
Why?
|
| Antineoplastic Agents | 4 | 2021 | 663 | 0.350 |
Why?
|
| Humans | 29 | 2025 | 63512 | 0.340 |
Why?
|
| Adenocarcinoma | 3 | 2024 | 349 | 0.340 |
Why?
|
| Immunotherapy | 4 | 2025 | 256 | 0.330 |
Why?
|
| Signal Transduction | 9 | 2025 | 3035 | 0.320 |
Why?
|
| Pancreas | 5 | 2024 | 152 | 0.320 |
Why?
|
| Mice, Inbred C57BL | 9 | 2024 | 3396 | 0.300 |
Why?
|
| Mitochondria | 3 | 2025 | 372 | 0.270 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2025 | 309 | 0.270 |
Why?
|
| Cell Proliferation | 7 | 2025 | 988 | 0.270 |
Why?
|
| Cellular Senescence | 2 | 2024 | 110 | 0.260 |
Why?
|
| Homeodomain Proteins | 2 | 2019 | 268 | 0.250 |
Why?
|
| Epithelial Cells | 3 | 2025 | 390 | 0.250 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 1 | 2025 | 17 | 0.240 |
Why?
|
| Thiolester Hydrolases | 1 | 2025 | 9 | 0.240 |
Why?
|
| Immunologic Surveillance | 1 | 2025 | 22 | 0.240 |
Why?
|
| Liver Neoplasms | 3 | 2023 | 297 | 0.230 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2025 | 108 | 0.230 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2025 | 181 | 0.230 |
Why?
|
| Cancer-Associated Fibroblasts | 1 | 2024 | 3 | 0.220 |
Why?
|
| ATP Citrate (pro-S)-Lyase | 1 | 2024 | 17 | 0.220 |
Why?
|
| Tumor Hypoxia | 1 | 2024 | 1 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2024 | 52 | 0.220 |
Why?
|
| Ovarian Neoplasms | 1 | 2025 | 150 | 0.220 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2025 | 213 | 0.210 |
Why?
|
| Immune Tolerance | 1 | 2024 | 176 | 0.210 |
Why?
|
| Hypoalbuminemia | 1 | 2023 | 7 | 0.200 |
Why?
|
| Thermogenesis | 1 | 2024 | 121 | 0.200 |
Why?
|
| Sulfonamides | 1 | 2024 | 127 | 0.200 |
Why?
|
| Adipose Tissue, Brown | 1 | 2024 | 118 | 0.200 |
Why?
|
| Steroid Hydroxylases | 1 | 2023 | 11 | 0.200 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2024 | 344 | 0.200 |
Why?
|
| Stress, Physiological | 1 | 2024 | 193 | 0.190 |
Why?
|
| Membrane Proteins | 2 | 2025 | 895 | 0.190 |
Why?
|
| MAP Kinase Signaling System | 1 | 2024 | 226 | 0.190 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2024 | 677 | 0.190 |
Why?
|
| Proto-Oncogene Proteins c-ets | 2 | 2023 | 19 | 0.190 |
Why?
|
| Pancreatitis | 2 | 2024 | 97 | 0.190 |
Why?
|
| Genes, myc | 1 | 2021 | 18 | 0.180 |
Why?
|
| Gene Deletion | 3 | 2019 | 309 | 0.180 |
Why?
|
| Calcium | 1 | 2025 | 575 | 0.180 |
Why?
|
| Prostatic Neoplasms | 1 | 2025 | 418 | 0.180 |
Why?
|
| Fibroblasts | 3 | 2022 | 394 | 0.180 |
Why?
|
| Protein Isoforms | 2 | 2019 | 197 | 0.180 |
Why?
|
| Chemoradiotherapy | 1 | 2021 | 67 | 0.180 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 87 | 0.170 |
Why?
|
| Epigenesis, Genetic | 1 | 2024 | 385 | 0.170 |
Why?
|
| Histones | 1 | 2024 | 481 | 0.170 |
Why?
|
| Mice, Inbred Strains | 1 | 2021 | 189 | 0.170 |
Why?
|
| Cell Differentiation | 3 | 2021 | 1354 | 0.170 |
Why?
|
| Esophageal Neoplasms | 1 | 2021 | 85 | 0.170 |
Why?
|
| Immunity, Innate | 2 | 2024 | 795 | 0.170 |
Why?
|
| Fanconi Anemia Complementation Group N Protein | 1 | 2019 | 1 | 0.160 |
Why?
|
| Calcium Signaling | 1 | 2021 | 157 | 0.160 |
Why?
|
| BRCA2 Protein | 1 | 2019 | 14 | 0.160 |
Why?
|
| Apoptosis | 3 | 2019 | 1079 | 0.160 |
Why?
|
| BRCA1 Protein | 1 | 2019 | 58 | 0.150 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2019 | 6 | 0.150 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 127 | 0.150 |
Why?
|
| Carcinoma | 1 | 2019 | 123 | 0.150 |
Why?
|
| Regulon | 1 | 2018 | 6 | 0.150 |
Why?
|
| Stem Cells | 2 | 2018 | 259 | 0.150 |
Why?
|
| Catenins | 1 | 2018 | 14 | 0.150 |
Why?
|
| Nanoparticles | 1 | 2024 | 513 | 0.140 |
Why?
|
| SOX9 Transcription Factor | 1 | 2018 | 7 | 0.140 |
Why?
|
| DNA Nucleotidyltransferases | 1 | 2017 | 6 | 0.140 |
Why?
|
| Wnt Signaling Pathway | 1 | 2018 | 81 | 0.140 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2023 | 449 | 0.140 |
Why?
|
| Keratin-15 | 1 | 2017 | 2 | 0.140 |
Why?
|
| Interleukins | 1 | 2017 | 80 | 0.130 |
Why?
|
| Interleukin-18 | 1 | 2017 | 74 | 0.130 |
Why?
|
| Esophagus | 1 | 2017 | 51 | 0.130 |
Why?
|
| Lung Neoplasms | 2 | 2021 | 676 | 0.130 |
Why?
|
| DNA Damage | 1 | 2019 | 287 | 0.130 |
Why?
|
| Smoothened Receptor | 1 | 2016 | 26 | 0.130 |
Why?
|
| Lymphocytes | 1 | 2017 | 201 | 0.130 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 242 | 0.130 |
Why?
|
| B7-H1 Antigen | 1 | 2016 | 57 | 0.130 |
Why?
|
| DNA-Binding Proteins | 2 | 2023 | 1186 | 0.120 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2015 | 6 | 0.120 |
Why?
|
| STAT5 Transcription Factor | 1 | 2015 | 14 | 0.120 |
Why?
|
| Collagen | 1 | 2016 | 123 | 0.120 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 16 | 0.120 |
Why?
|
| Trans-Activators | 1 | 2017 | 311 | 0.120 |
Why?
|
| Phenotype | 2 | 2016 | 1207 | 0.120 |
Why?
|
| NF-kappa B | 1 | 2017 | 469 | 0.120 |
Why?
|
| Interleukin-6 | 1 | 2016 | 321 | 0.110 |
Why?
|
| RNA-Binding Proteins | 1 | 2018 | 435 | 0.110 |
Why?
|
| Transcription Factors | 2 | 2023 | 1513 | 0.110 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2015 | 188 | 0.110 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 897 | 0.110 |
Why?
|
| Gene Expression | 1 | 2016 | 840 | 0.100 |
Why?
|
| Female | 7 | 2025 | 32912 | 0.100 |
Why?
|
| Stilbenes | 1 | 2012 | 48 | 0.090 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2012 | 88 | 0.090 |
Why?
|
| Apoptotic Protease-Activating Factor 1 | 1 | 2011 | 2 | 0.090 |
Why?
|
| DNA, Mitochondrial | 1 | 2012 | 87 | 0.090 |
Why?
|
| Mice, Nude | 2 | 2024 | 277 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 53 | 0.090 |
Why?
|
| Caspases | 1 | 2012 | 174 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2018 | 1617 | 0.090 |
Why?
|
| Curcumin | 1 | 2011 | 80 | 0.080 |
Why?
|
| Autophagy | 1 | 2012 | 225 | 0.080 |
Why?
|
| Male | 7 | 2025 | 29927 | 0.080 |
Why?
|
| Cadherins | 2 | 2021 | 80 | 0.080 |
Why?
|
| Cell Movement | 2 | 2021 | 454 | 0.070 |
Why?
|
| Regeneration | 2 | 2018 | 95 | 0.070 |
Why?
|
| Mutation | 3 | 2021 | 2615 | 0.060 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2016 | 40 | 0.060 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2025 | 22 | 0.060 |
Why?
|
| Snail Family Transcription Factors | 1 | 2025 | 28 | 0.060 |
Why?
|
| Calcium Channels | 1 | 2025 | 103 | 0.060 |
Why?
|
| Citric Acid Cycle | 1 | 2024 | 29 | 0.060 |
Why?
|
| Cell Survival | 2 | 2017 | 575 | 0.060 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2024 | 21 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 2 | 2017 | 676 | 0.050 |
Why?
|
| F-Box Proteins | 1 | 2024 | 15 | 0.050 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2024 | 17 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 1 | 2025 | 172 | 0.050 |
Why?
|
| Methylation | 1 | 2024 | 129 | 0.050 |
Why?
|
| Netrin Receptors | 1 | 2023 | 1 | 0.050 |
Why?
|
| Netrin-1 | 1 | 2023 | 4 | 0.050 |
Why?
|
| Retinoids | 1 | 2023 | 12 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2018 | 1277 | 0.050 |
Why?
|
| Albumin-Bound Paclitaxel | 1 | 2023 | 1 | 0.050 |
Why?
|
| Hepatic Stellate Cells | 1 | 2023 | 24 | 0.050 |
Why?
|
| Fatty Acids | 1 | 2024 | 200 | 0.050 |
Why?
|
| Edema | 1 | 2023 | 43 | 0.050 |
Why?
|
| Albumins | 1 | 2023 | 35 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2018 | 2157 | 0.050 |
Why?
|
| Paclitaxel | 1 | 2023 | 101 | 0.050 |
Why?
|
| Interferon Type I | 1 | 2024 | 187 | 0.050 |
Why?
|
| Disease Progression | 2 | 2017 | 1173 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 864 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2024 | 758 | 0.050 |
Why?
|
| Precision Medicine | 1 | 2021 | 120 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 198 | 0.040 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 58 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2024 | 1007 | 0.040 |
Why?
|
| Receptors, Estrogen | 1 | 2020 | 128 | 0.040 |
Why?
|
| Etoposide | 1 | 2019 | 34 | 0.040 |
Why?
|
| Deoxycytidine | 1 | 2019 | 42 | 0.040 |
Why?
|
| Oncogenes | 1 | 2018 | 68 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 1008 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2018 | 209 | 0.030 |
Why?
|
| Palatine Tonsil | 1 | 2017 | 9 | 0.030 |
Why?
|
| Transcriptome | 1 | 2021 | 387 | 0.030 |
Why?
|
| Interleukin-15 | 1 | 2017 | 25 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2017 | 22 | 0.030 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2017 | 9 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2017 | 50 | 0.030 |
Why?
|
| DNA Repair | 1 | 2019 | 248 | 0.030 |
Why?
|
| Phosphoproteins | 1 | 2018 | 220 | 0.030 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2016 | 1 | 0.030 |
Why?
|
| L-Selectin | 1 | 2016 | 14 | 0.030 |
Why?
|
| Janus Kinases | 1 | 2016 | 16 | 0.030 |
Why?
|
| STAT Transcription Factors | 1 | 2016 | 17 | 0.030 |
Why?
|
| Hyaluronan Receptors | 1 | 2016 | 35 | 0.030 |
Why?
|
| Transforming Growth Factor alpha | 1 | 2016 | 15 | 0.030 |
Why?
|
| Zinc Finger Protein Gli2 | 1 | 2016 | 26 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2019 | 622 | 0.030 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2016 | 48 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 190 | 0.030 |
Why?
|
| Aged | 2 | 2023 | 14469 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2016 | 190 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 2015 | 16 | 0.030 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2016 | 47 | 0.030 |
Why?
|
| Genes, ras | 1 | 2015 | 27 | 0.030 |
Why?
|
| ErbB Receptors | 1 | 2016 | 114 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2016 | 173 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 2018 | 320 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2015 | 69 | 0.030 |
Why?
|
| Genes, p53 | 1 | 2015 | 52 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 457 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2018 | 276 | 0.030 |
Why?
|
| Forkhead Transcription Factors | 1 | 2015 | 128 | 0.030 |
Why?
|
| Models, Biological | 1 | 2020 | 1180 | 0.030 |
Why?
|
| Molecular Targeted Therapy | 1 | 2015 | 130 | 0.030 |
Why?
|
| Actins | 1 | 2016 | 259 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 878 | 0.030 |
Why?
|
| Homeostasis | 1 | 2017 | 368 | 0.030 |
Why?
|
| Cell Line | 1 | 2019 | 2040 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2017 | 525 | 0.030 |
Why?
|
| Survival Rate | 1 | 2016 | 851 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2021 | 3301 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2015 | 212 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2015 | 936 | 0.030 |
Why?
|
| Amino Acid Chloromethyl Ketones | 1 | 2011 | 11 | 0.020 |
Why?
|
| Mitochondrial Membranes | 1 | 2011 | 7 | 0.020 |
Why?
|
| Caspase Inhibitors | 1 | 2011 | 21 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 719 | 0.020 |
Why?
|
| Cytochromes c | 1 | 2011 | 29 | 0.020 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2011 | 48 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2011 | 51 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2011 | 110 | 0.020 |
Why?
|
| Lentivirus | 1 | 2011 | 66 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 234 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2011 | 108 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 202 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 381 | 0.020 |
Why?
|
| Cytosol | 1 | 2011 | 180 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 373 | 0.020 |
Why?
|
| Time Factors | 1 | 2015 | 3770 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2011 | 1537 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2011 | 921 | 0.010 |
Why?
|
| Middle Aged | 1 | 2021 | 17641 | 0.010 |
Why?
|